SeaCrest Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
LMFP
SI
GGI
QCM
MIM
DLA
BCAM
MGIA
ERP
SeaCrest Wealth Management's NVS Position: Q2 2026 in Review
SeaCrest Wealth Management opened a new position in Novartis (NVS) in Q2 2026: 1,357 shares worth $213K. The stake represents 0.02% of the portfolio and ranks #511 among its holdings. This is a return to the name: SeaCrest Wealth Management previously reported a position in NVS as recently as Q2 2025.
SeaCrest Wealth Management first reported a position in NVS in Q4 2017 and has held it in 17 quarters since. The position peaked at $284K in Q3 2023. 366 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- SeaCrest Wealth Management held 1,357 shares of Novartis worth $213K as of Q2 2026.
- Novartis was a new SeaCrest Wealth Management position in Q2 2026.
- Novartis made up 0.02% of SeaCrest Wealth Management's portfolio in Q2 2026, its #511 holding.
- SeaCrest Wealth Management first reported a position in Novartis in Q4 2017 and has held it in 17 quarters since.
- SeaCrest Wealth Management's Novartis position peaked at $284K in Q3 2023.
- 366 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.